Biochips Market Size & Share, by Type (DNA Chips, Protein Chips, Lab-on-a-Chip); Function (Multi-purpose, Bi-functional, Enzyme, Cleaning Chips); Fabrication Technology (Microarrays, Microfluidics); Application (Drug Discovery, Clinical Diagnostics, Agriculture Biotechnology); End-user (Pharmaceuticals, Hospitals & Diagnostic Centers, Academic Research Institutes) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 2900
  • Published Date: Mar 10, 2023
  • Report Format: PDF, PPT

Companies Dominating the Biochips Landscape

top-features-companies
    • Dynamic Biosensors GmbH
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • PerkinElmer Inc.
    • Bio-Rad Laboratories, Inc.
    • Illumina, Inc.
    • ABTECH Scientific, Inc.
    • Standard BioTools Inc.
    • Merck KGaA
    • LI-COR, Inc.
    • Cepheid
    • Agilent Technologies, Inc.

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Bio-Rad Laboratories, Inc. announced a collaboration with Element Biosciences, Inc. to demonstrate the Bio-Rad SEQuoia RNA Sequencing Library Preparation portfolio with the Element AVITI Benchtop Sequencer. Using the new Avidity Sequencing chemistry on the Element AVITI Sequencing Platform, Bio-Rad's SEQuoia RNA Complete Stranded RNA Library Prep Kit and SEQuoia Express Stranded RNA Library Prep Kit are estimated to be easily used to achieve high RNA sequencing accuracy and repeatability across different samples and inputs.

  • Merck KGaA announced the partnership with Artios Pharma to jointly develop multiple precision oncology drugs over the next three years as part of a global research collaboration. By leveraging Artios' proprietary nuclease targeting discovery platform, the companies are projected to jointly identify multiple synthetic lethal targets for precision cancer drug candidates.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 2900
  • Published Date: Mar 10, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Worldwide growing prevalence of cancer, a rising proportion of communicable disorders, and an upsurge in the development and approval of novel drugs are the major factors driving the market growth.

The market is anticipated to attain a CAGR of 14% over the forecast period, i.e., 2023-2035.

High manufacturing cost of biochips, lack of awareness regarding biochips in emerging economies, and concerned risks of biohacking and privacy are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Dynamic Biosensors GmbH, PerkinElmer Inc., Bio-Rad Laboratories, Inc., Illumina, Inc., ABTECH Scientific, Inc., Standard BioTools Inc., Merck KGaA, LI-COR, Inc., and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type, function, fabrication technology, application, end-user, and region.

The DNA chips segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying